{"entity":{"id":"unicar-therapy","kind":"company","name":"Unicar-Therapy","aka":["Shanghai Unicar-Therapy Bio-medicine Technology","优卡迪"],"tldr":"Unicar-Therapy is a China-based cell therapy company that leads 2 cancer trials in OnCo, testing the CAR-T products U16 and U32 in non-Hodgkin lymphoma and acute myeloid leukaemia.","summary":"Unicar-Therapy is a Shanghai CAR-T developer founded in 2015 that builds its own cell therapy products on in-house platforms with integrated manufacturing. Its registered pipeline covers blood cancers and solid tumours. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT05768529 (phase 1/2, Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma) and NCT07036250 (phase 1/2, Clinical Study of U32 in Patients With Acute Myeloid Leukemia). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"http://www.unicar-therapy.com"},{"label":"ClinicalTrials.gov: trials led by Unicar-Therapy","url":"https://clinicaltrials.gov/search?lead=Shanghai%20Unicar-Therapy%20Bio-medicine%20Technology%20Co.%2CLtd"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["non-hodgkin-lymphoma","aml"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05768529","nct07036250"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Shanghai","country":"CN","companyType":"cell-therapy","website":"http://www.unicar-therapy.com","founded":2015,"stage":"startup","investors":[],"funding":[]},"route":"/companies/unicar-therapy/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"trial":[{"id":"nct05768529","kind":"trial","name":"Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","route":"/trials/nct05768529/"},{"id":"nct07036250","kind":"trial","name":"Clinical Study of U32 in Patients With Acute Myeloid Leukemia","route":"/trials/nct07036250/"}]}}